Drug News

Added 9 hours ago Drug news

CHMP positive for solriamfetol to improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy (with or without cataplexy) or obstructive sleep apnea .- Jazz Pharma

Jazz Pharmaceuticals plc announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a...

Added 9 hours ago Drug news

Advisory Committee recommends Vascepa to reduce the risk of cardiovascular events.- Amarin Corpn.

Amarin Corporation plc announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA has voted unanimously (16-0)...

Added 9 hours ago Drug news

FOURIER outcomes phase III study of Repatha shows effectiveness in myocardial infarction.- Amgen

Amgen announced a new analysis from the Repatha (evolocumab) cardiovascular outcomes (FOURIER) phase III study that evaluates the effectiveness of...

Added 1 day ago Drug news

European Commission approves Qtrilmet to improve glycaemic control in adults with type 2 diabetes.- AstraZeneca

AstraZeneca announced that the European Commission (EC) has approved Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets to improve glycaemic...

Added 1 day ago Drug news

Phase III BE READY study of UCB 4940 met primary endpoints in plaque psoriasis.- UCB

UCB announced positive results from BE READY, the second of three Phase III studies this year to report findings on...

Added 1 day ago Drug news

FDA approves Fetroja for complicated urinary tract infections.- Shionogi

The FDA has approved Fetroja (cefiderocol), from Shionogi, an antibacterial drug for treatment of patients 18 years of age or...

Added 1 day ago Drug news

Adakveo approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease.- Novartis

Novartis announced that the FDA approved Adakveo (crizanlizumab), previously known as SEG 101, to reduce the frequency of vaso-occlusive crises...

Added 1 day ago Drug news

CHMP recommends approval in final guidance for Tavalisse in chronic immune thrombocytopenia.- Rigel Pharma

Rigel Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines...

Added 1 day ago Drug news

CHMP recommends approval of Kadcyla for adjuvant treatment of HER2-positive early breast cancer.- Roche

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval...

Added 1 day ago Drug news

FDA approves Brukinsa to treat Mantle Cell Lymphoma- BeiGene

BeiGene, Ltd. announced that Brukinsa (zanubrutinib) has received accelerated approval from the FDA as a treatment for mantle cell lymphoma...

Search all news articles